Latest Investor Relations News

Pengana Private Equity Trust has updated the Dividend Reinvestment Plan (DRP) price for its upcoming ordinary distribution, maintaining a steady payout of AUD 0.03176 per unit for the half-year ending December 2024.

Amcor plc has taken a pivotal step in its proposed merger with Berry Global by filing the definitive joint proxy statement with the SEC, setting the stage for shareholder votes in February. Integration planning is well underway as both companies prepare to unite their packaging expertise.

Stockland updates its dividend distribution details, confirming an 8 cent per security payout and announcing the Dividend Reinvestment Plan price ahead of the February payment date.

Powerhouse Ventures Limited reports a robust quarterly performance with a notable uplift in net tangible assets to 10.4 cents per share, driven by strategic acquisitions and active investment management.

SelfWealth Ltd reported a 4% revenue increase and sustained profitability in H1 2025, while advancing a major transformation program and entering a proposed acquisition deal with Bell Financial Group.

Latin Resources Limited confirms the legal effectiveness of its acquisition by Pilbara Minerals Limited via share and option schemes, setting the stage for key trading milestones.

NeuRizer Ltd has completed a $150,000 private share placement, issuing 100 million new shares to support its NeuRizer Urea Project and general working capital needs.

Murray Cod Australia Limited has announced a 10-for-1 security consolidation affecting all ordinary shares and options, aiming to simplify its capital structure ahead of resumed trading in February 2025.

Nimy Resources has addressed an ASX inquiry regarding recent spikes in its share price and trading volume, confirming no undisclosed information but highlighting ongoing work on its maiden JORC Exploration Target for gallium.

ARENA REIT has updated its dividend distribution details for the quarter ending December 2024, confirming a 4.56 cent payout and outlining its Dividend Reinvestment Plan pricing.

Artrya Limited has responded to an ASX price query following a notable surge in its share price, confirming no undisclosed information and adherence to continuous disclosure rules.

Fonterra Shareholders' Fund has secured conditional approval to delist from the ASX, aiming to consolidate its trading on the NZX by late February 2025. This move is expected to streamline operations and reduce costs for unitholders.